Ghosh et al. (84) used Nanosight/TEM/immunoblotting and anti-Alix/anti-GRP78/anti-Asgr2 to validate the presence of HBV/HCV-infected low methemoglobin non-hepatocellular carcinoma (non-HCC) exosomes. Here, HBG2 is linked to hepatocellular carcinoma.